AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma

Cancer Investigation

Volumn 27, Issue 6, 2009, Pages 673-681

  Ma, Xiao Juan ^a   Huang, Rui ^a   Kuang, An Ren ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

fetoprotein (AFP); 131I; Hepatocellular carcinoma (HCC); Human sodium iodide symporter (hNIS); Targeted radioiodine therapy

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; IODINE 125; IODINE 131; LUCIFERASE; SODIUM IODIDE SYMPORTER; AFP PROTEIN, HUMAN; COTRANSPORTER; PERCHLORATE; PERCHLORIC ACID; RADIOACTIVE IODINE;

ARTICLE; CANCER GENE THERAPY; CELL STRAIN HEPG2; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA SEQUENCE; ENHANCER REGION; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RADIOISOTOPE THERAPY; WESTERN BLOTTING; WHOLE BODY IMAGING; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG SCREENING; GENE THERAPY; GENE VECTOR; GENETICS; LIVER TUMOR; MALE; METABOLISM; NUDE MOUSE; REPORTER GENE; TRANSPORT AT THE CELLULAR LEVEL;

ADENOVIRIDAE; ALPHA-FETOPROTEINS; ANIMALS; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PERCHLORIC ACID; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SYMPORTERS; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67649958401     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802620885     Document Type: Article

References (33)

1. Levin, B.; Amos, C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 1995, 332(19), 1294-1296.
2. el-Serag, H.B. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001, 5(1), 87-107.
3. Chan, D.W.; Kelsten, M.; Rock, R.; Bruzek, D. Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein. Clin Chem 1986, 32(7), 1318-1322. (Pubitemid 17020829)
4. Johnson, P.J. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999, 14(Suppl.), 32-36.
5. Watanabe, K.; Saito, A.; Tamaoki, T. Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J Biol Chem 1987, 262(10), 4812-4818. (Pubitemid 17102857)
6. Ido, A.; Nakata, K.; Kato, Y.; Nakao, K.; Murata, K.; Fujita, M.; Ishii, N.; Tamaoki, T.; Shiku, H.; Nagataki, S. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of the human α-fetoprotein gene promoter. Cancer Res 1995, 55(14), 3105-3109.
7. Nettelbeck, D.M.; Jérôme, V.; Müller, R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther 1998, 5(12), 1656-1664. (Pubitemid 29008336)
8. Takikawa, H.; Mafune, K.; Hamada, H.; Nettelbeck, D.M.; Müller, R.; Makuuchi, M.; Kaminishi, M. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma. Int J Oncol 2003, 22(5), 1051-1056.
9. Ido, A.; Uto, H.; Moriuchi, A.; Nagata, K.; Onaga, Y.; Onaga, M.; Hori, T.; Hirono, S.; Hayashi, K.; Tamaoki, T.; Tsubouchi, H. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human a-fetoprotein promoter. Cancer Res 2001, 61(7), 3016-3021. (Pubitemid 32691948)
10. Byeong-Cheol, A.; Min Jeong, R.; Sohn Joo, A.; Sun Mi, Y.; Seung Hee, C.; Jeongsoo, Y.; In-Kyu, L.; Jae-Tae, L.; Kyu-Bo, L. Construction of a highly hepatoma specific adenoviral vector system carrying NIS gene activated by AFP enhancer. J Nucl Med 2006, 47(Suppl. 1), 409P.
11. Vieja, A.D.L.; Dohan, O.; Levy, O.; Carrasco, N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000, 80(3), 1083-1105. (Pubitemid 30452012)
12. Dai, G.; Levy, O.; Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature 1996, 379(6564), 458-460.
13. Dohán, O.; De la Vieja, A.; Paroder, V.; Riedel, C.; Artani, M.; Reed, M.; Ginter, C.S.; Carrasco, N. The Sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003, 24(1), 48-77. [PMID: 12588808] (Pubitemid 36223279)
14. Spitzweg, C.; Harrington, K.J.; Pinke, L.A.; Vile, R.G.; Morris, J.C. The sodium/iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001, 86(7), 3327-3335. (Pubitemid 32673505)
15. Mandell, R.B.; Mandell, L.Z.; Link, C.J., Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999, 59(3), 661-668.
16. Boland, A.; Ricard, M.; Opolon, P.; Bidart, J.M.; Yeh, P.; Filetti, S.; Schlumberger, M.; Perricaudet, M. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000, 60(13), 3484-3492. (Pubitemid 30482168)
17. Nakamoto, Y.; Saga, T.; Misaki, T.; Kobayashi, H.; Sato, N.; Ishimori, T.; Kosugi, S.; Sakahara, H.; Konishi, J. Establishment and characterization of a breast cancer cell line expressing Na/I symporters for radioiodide concentrator gene therapy. J Nucl Med 2000, 41(11), 1898-1904.
18. Haberkorn, U.; Henze, M.; Altmann, A.; Jiang, S.;Morr, I.; Mahmut, M.; Peschke, P.; Kübler, W.; Debus, J.; Eisenhut, M. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001, 42(2), 317-325.
19. Schipper, M.L.; Weber, A.; Béhé, M.; Göke, R.; Joba, W.; Schmidt, H.; Bert, T.; Simon, B.; Arnold, R.; Heufelder, A.E.; Behr, T.M. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells. Cancer Res 2003, 63(6), 1333-1338. (Pubitemid 36348713)
20. Kakinuma, H.; Bergert, E.R.; Spitzweg, C.; Cheville, J.C.; Lieber, M.M.; Morris, J.C. Probasin promoter (ARR2PB)-driven, prostatespecific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 2003, 63(22), 7840-7844.
21. Huang, R.; Kuang, A.; Yu H.; Ma C.; Tang, G. Construction of the recombinant adenovirus carrying sodium/iodide symporter gene. J Biomed Eng 2005, 22(4), 765-768.
22. Ueki, T.; Nakata, K.; Mawatari, F.; Tsuruta, S.; Ido, A.; Ishikawa, H.; Nakao, K.; Kato, Y.; Ishii, N.; Eguchi, K. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice. Int J Mol Med 1998, 1(4), 671-675.
23. Uto, H.; Ido, A.; Hori, T.; Hirono, S.; Hayashi, K.; Tamaoki, T.; Tsubouchi, H. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene. Biochem Biophys ResCommun 1999, 265(2), 550-555.
24. Nakabayashi, H.;Watanabe, K.; Saito, A.; Otsuru, A.; Sawadaishi, K.; Tamaoki, T. Transcriptional regulation of α-fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989, 264(1), 266-271.
25. Nakabayashi, H.; Hashimoto, T.; Miyao, Y.; Tjong, K.K.; Chan, J.; Tamaoki, T. A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma. Mol Cell Biol 1991, 11(12), 5885-5893.
26. Mawatari, F.; Tsuruta, S.; Ido, A.; Ueki, T.; Nakao, K.; Kato, Y.; Tamaoki, T.; Ishii, N.; Nakata, K. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 1998, 5(5), 301-306.
27. Ishikawa, H.; Nakata. K.; Mawatari, F.; Ueki, T.; Tsuruta, S.; Ido, A.; Nakao, K.; Kato, Y.; Ishii, N.; Eguchi, K. Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for the hepatocellular carcinoma. Gene Ther 1999, 6(4), 465-470.
28. Cao, G.; Kuriyama, S.; Tsujinoue, H.; Chen, Q.L. Akira Mrroro, ZH Qi. A novel approach for inducing enhanced and selective transgene expression in hepatocellular carcinoma cells. Int J Cancer 2000, 87(2), 247-252.
29. Cao, G.; Kuriyama, S.; Gao, J.; Nakatani, T.; Chen, Q.; Yoshiji, H.; Zhao, L.; Kojima, H.; Dong, Y.; Fukui, H.; Hou, J. Gene therapy for hepatocellular carcinoma based on tumor-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Eur J Cancer 2001, 37(1), 140-147. (Pubitemid 32119371)
30. Spitzweg, C.; Zhang, S.; Bergert, E.R.; Castro, M.R.; McIver, B.; Heufelder, A.E.; Tindall, D.J.; Young, C.Y.; Morris, J.C. Prostatespecific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res 1999, 59(9), 2136-2141.
31. Kang, J.H.; Chung, J.K.; Lee, Y.J.; Shin, J.H.; Jeong, J.M.; Lee, D.S.; Lee, M.C. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. J Nucl Med 2004, 45(9), 1571-1576. (Pubitemid 47618512)
32. Haberkorn, U.; Henze, M.; Altmann, A.; Jiang, S.;Morr, I.; Mahmut, M.; Peschke, P.; K̈ubler, W.; Debus, J.; Eisenhut, M. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 2001, 42(2), 317-325.
33. Shimura, H.; Haraguchi, A.; Miyazaki, A.; Endo, T.; Onaya, T. Iodide uptake and 131I experimental therapy in transplanted undifferentiated thyroid cancer cells expressing the Na/I symporter gene. Endocrinology 1997, 138(10), 4493-4496.